Papp, K. et al. 2022. Time to Loss of Response following Withdrawal of Ixekizumab in Patients with Moderate-to-Severe Psoriasis. Acta Dermato-Venereologica. 102, (Mar. 2022), adv00672. DOI:https://doi.org/10.2340/actadv.v102.1984.